ArticleJournal of neuroinflammation2023

Pharmacologic inhibition of NLRP3 reduces the levels of α-synuclein and protects dopaminergic neurons in a model of Parkinson's disease.

Jesus Amo-Aparicio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.